Inhibikase Therapeutics
Earnings Surprise
Analysts estimated IKT earnings of $-0.10 per share this quarter (Q4). IKT's actual earnings were $-0.09 per share.
IKT EPS surprise of 13.63%Analysts estimated IKT earnings of $-0.09 per share this quarter (Q2). IKT's actual earnings were $-0.11 per share.
IKT EPS surprise of -21.01%Analysts estimated IKT earnings of $-0.11 per share this quarter (Q1). IKT's actual earnings were $-0.17 per share.
IKT EPS surprise of -60.23%Analysts estimated IKT earnings of $-0.09 per share this quarter (Q4). IKT's actual earnings were $-0.50 per share.
IKT EPS surprise of -471.43%Analysts estimated IKT earnings of $-0.37 per share this quarter (Q3). IKT's actual earnings were $-0.65 per share.
IKT EPS surprise of -73.94%Analysts estimated IKT earnings of $-0.80 per share this quarter (Q1). IKT's actual earnings were $-0.73 per share.
IKT EPS surprise of 8.51%Analysts estimated IKT earnings of $-0.86 per share this quarter (Q4). IKT's actual earnings were $-0.64 per share.
IKT EPS surprise of 34.14%Analysts estimated IKT earnings of $-1.13 per share this quarter (Q3). IKT's actual earnings were $-0.86 per share.
IKT EPS surprise of -23.97%